Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of the Effects of Clopidogrel on Soluble CD40 Ligand, Endothelial Function and Blood Pressure

NCT01112137 is registered in ClinicalTrials.gov with University of Cologne as lead sponsor.

NCT NCT01112137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01112137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of the Effects of Clopidogrel on Soluble CD40 Ligand, Endothelial Function and Blood Pressure
Lead sponsor
University of Cologne
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
April 30, 2010
Enrollment
46 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, endothelial function, platelet function